Cipla Q4 Results
- BSE: 500087
- NSE: CIPLA
- ISIN: INE059A01026
- Sector: Biotechnology & Drugs
BSE
1,502.25
6.85 (0.46%)
6.85 (0.46%)Volume65.66 K
Updated: Thu 15 May, 2025 | 15:55:35
NSE
1,502.207.40 (0.50%)
7.40 (0.50%)Volume3.92 M
Updated: Thu 15 May, 2025 | 15:52:02
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹6,729.69 Cr.(9.19%)
- Operating Profit₹1,228.86 Cr.(19.59%)
- Profit After Tax₹1,221.84 Cr.(30.12%)
- Operating Margin18.26%(9.53%)
Note: Comparison is on YoY basis
Quarterly - Cipla Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 6,729.69 | 7,072.97 | -4.85% | 6,163.24 | 9.19% |
| Selling/ General/ Admin Expenses Total | 1,233.10 | 1,197.62 | 2.96% | 1,084.23 | 13.73% |
| Depreciation/ Amortization | 308.73 | 279.80 | 10.34% | 288.34 | 7.07% |
| Other Operating Expenses Total | 1,769.98 | 1,622.35 | 9.10% | 1,713.03 | 3.32% |
| Total Operating Expense | 5,500.83 | 5,363.85 | 2.55% | 5,135.72 | 7.11% |
| Operating Income | 1,228.86 | 1,709.12 | -28.10% | 1,027.52 | 19.59% |
| Net Income Before Taxes | 1,504.30 | 1,916.09 | -21.49% | 1,259.26 | 19.46% |
| Net Income | 1,221.84 | 1,570.51 | -22.20% | 939.04 | 30.12% |
| Diluted Normalized EPS | 15.12 | 19.43 | -22.18% | 11.63 | 29.97% |